CausalSentinel

Protein Dossier — DPEP1 (Dipeptidase 1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Schizophrenia 0.104 0.0348 0.00278 Wald ratio 1 cis NA
Amyotrophic lateral sclerosis 0.132 0.0572 0.0214 Wald ratio 1 cis NA
Femoral neck bone mineral density -0.0535 0.0244 0.0282 Wald ratio 1 cis NA
Low grade serous ovarian cancer -0.314 0.153 0.0397 Wald ratio 1 cis NA
Myocardial infarction 0.0618 0.0357 0.0837 Wald ratio 1 cis NA
Coronary heart disease 0.0488 0.0321 0.128 Wald ratio 1 cis NA
Neuroticism -0.0192 0.0128 0.134 Wald ratio 1 cis NA
Thalamus volume 28.3 20.5 0.169 Wald ratio 1 cis NA
Pallidum volume 8.37 6.27 0.181 Wald ratio 1 cis NA
Putamen volume 25.3 19.7 0.2 Wald ratio 1 cis NA
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.0374 0.0371 0.313 Wald ratio 1 cis NA
Depressive symptoms -0.0128 0.0128 0.317 Wald ratio 1 cis NA
…and 5 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

191 association rows across 128 traits (177 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating DPEP1 levels 1e-2323 rs9673342 3 GCST90860743 no MR -> candidate analysis
Urine prolylglycine levels in chronic kidney disease 9e-369 rs2434858 1 GCST90265875 no MR -> candidate analysis
Dipeptidase 1 levels 8e-366 rs409170 3 GCST90247341 no MR -> candidate analysis
Hair color 1e-300 rs12930346 1 GCST007082 no MR -> candidate analysis
DPEP1 protein levels 2e-278 rs76820443 3 GCST90469030 no MR -> candidate analysis
Cys-gly, oxidized levels 9e-259 rs409170 3 GCST90245155 no MR -> candidate analysis
Metabolite levels (cys-gly, oxidized) 2e-191 rs1126464 5 GCST90299957 no MR -> candidate analysis
Serum metabolite levels 2e-122 rs1126464 4 GCST012020 no MR -> candidate analysis
Plasma cys-gly, oxidized levels in chronic kidney disease 2e-114 rs409170 1 GCST90264973 no MR -> candidate analysis
Urine N-lactoyl leucine levels in chronic kidney disease 2e-110 rs2460451 1 GCST90265629 no MR -> candidate analysis
Urinary metabolite levels in chronic kidney disease 1e-99 rs420332 4 GCST009733 no MR -> candidate analysis
Serum levels of protein DPEP1 5e-80 rs258341 1 GCST90090302 no MR -> candidate analysis
…and 116 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 212 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
osteoarthritis 0.832 common-variant locus no MR -> candidate analysis
skin cancer 0.636 common-variant locus no MR -> candidate analysis
skin neoplasm 0.573 common-variant locus no MR -> candidate analysis
actinic keratosis 0.551 common-variant locus no MR -> candidate analysis
hypertensive disorder 0.525 common-variant locus no MR -> candidate analysis
Pain 0.506 common-variant locus no MR -> candidate analysis
carpal tunnel syndrome 0.485 common-variant locus no MR -> candidate analysis
chronic kidney disease 0.476 common-variant locus no MR -> candidate analysis
myasthenia gravis 0.464 common-variant locus no MR -> candidate analysis
hyperuricemia 0.43 common-variant locus no MR -> candidate analysis
melanoma 0.35 common-variant locus no MR -> candidate analysis
urolithiasis 0.33 common-variant locus no MR -> candidate analysis
liver disorder 0.33 common-variant locus no MR -> candidate analysis
arthropathy 0.206 common-variant locus no MR -> candidate analysis
essential hypertension 0.17 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 15 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 2 known modulators (Dipeptidase 1)
gnomAD constraint pLI=4.2e-20, LOEUF=1.5 — LoF-tolerant
GWAS Catalog 196 unique SNPs / 523 rows
ClinVar 139 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance